Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 09/29/2023 | Q3 2023 | N/A | -$1.18 | N/A | N/A | $0 |
| 12/30/2022 | Q4 2022 | N/A | -$0.54 | N/A | N/A | $0 |
| 09/29/2022 | Q3 2022 | N/A | -$0.51 | N/A | N/A | $0 |
The conference call for RayzeBio Inc.'s latest earnings report can be listened to online.
The conference call transcript for RayzeBio Inc.'s latest earnings report can be read online.
RayzeBio Inc. (:RYZB) has a recorded net income of $-68,600,000.RayzeBio Inc. has generated $-1.75 earnings per share over the last four quarters.
RayzeBio Inc. (:RYZB) has a price-to-earnings ratio of -35.73 and price/earnings-to-growth ratio is -0.36.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED